(PharmaNewsWire.Com, April 19, 2023 ) Maximize Market research expects, the Blood Screening Market to grow from USD 2.49 Bn in 2021 to USD 4.69 Bn in 2029 at a CAGR of 8.2 percent.
Blood Screening Market Report Scope and Research Methodology
The report provides a detailed analysis of Blood Screening Market dynamics and regional insights. To collect and analyze the data for the market report, primary and secondary research methodologies were employed along with PORTER and PESTLE analysis. The bottom-up approach was used to estimate the Blood Screening Market size.
The Blood Screening Market is driven by the increase in the prevalence of infectious diseases, the growing number of blood donations and the growth of the healthcare industry. The market growth is expected to be hampered by the high costs of the instruments and inadequate infrastructure for blood screening.
Blood Screening Market Regional Insights
During the forecast period, North America is expected to grow at a significant CAGR for the Blood Screening Market. The regional market is driven by the increasing expenditure on the healthcare sector and the growing prevalence of chronic disorders.
Blood Culture Tests Market- The market size is expected to reach USD 10.70 Bn by 2029 at a CAGR of 11 percent during the forecast period.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
